CVE-2026-109652Frappe ERPNext before 15.119.1 Server-Side Template Injection via Message Fields
Updated under an hour ago ()
Does this affect you?
It affects frappe erpnext. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.30%, higher than 22% of scored CVEs.
Do this next
Free account, 1 product
Frappe ERPNext before 15.119.1 and 16.x before 16.32.0 contains a server-side template injection vulnerability because user-controlled message fields are not validated before template rendering, allowing expressions to run in an unrestricted context. Authenticated attackers holding a common operational role can inject template expressions to read and write arbitrary database data, delete documents, send outbound requests from the server, and send mail from the site.
- CVSS
- 8.8 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-1336
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.30% (percentile 22)
- Assigned by
- VulnCheck
- NVD analysis
- Deferred
- Record last updated
- Oct 14, 2026
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
frappe erpnext frappe:erpnext (from the name) | before 15.119.1; from 16.0.0-beta.1 before 16.32.0; 15.119.1 not affected; 16.32.0 not affected | CNA record |
References
- https://github.com/frappe/erpnext/security/advisories/GHSA-6w83-8777-v93qvendor-advisory
- https://www.vulncheck.com/advisories/frappe-erpnext-before-15.119.1-server-side-template-injection-via-message-fieldsthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.